25 related articles for article (PubMed ID: 14716674)
1. Erythropoietin signaling promotes transplanted progenitor cell survival.
Jia Y; Warin R; Yu X; Epstein R; Noguchi CT
FASEB J; 2009 Sep; 23(9):3089-99. PubMed ID: 19417086
[TBL] [Abstract][Full Text] [Related]
2. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K
Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733
[TBL] [Abstract][Full Text] [Related]
3. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells.
Xu R; Kume A; Matsuda KM; Ueda Y; Kodaira H; Ogasawara Y; Urabe M; Kato I; Hasegawa M; Ozawa K
J Gene Med; 1999; 1(4):236-44. PubMed ID: 10738556
[TBL] [Abstract][Full Text] [Related]
4. In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene.
Kume A; Koremoto M; Xu R; Okada T; Mizukami H; Hanazono Y; Hasegawa M; Ozawa K
J Gene Med; 2003 Mar; 5(3):175-81. PubMed ID: 12666183
[TBL] [Abstract][Full Text] [Related]
5. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
6. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
7. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of erythropoietin receptor transgenes.
Kirby SL
Cytokines Cell Mol Ther; 1999 Jun; 5(2):97-104. PubMed ID: 10515682
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches.
Dirksen U; Moritz T; Burdach S; Flasshove M; Hanenberg H
Klin Padiatr; 1999; 211(4):329-35. PubMed ID: 10472572
[TBL] [Abstract][Full Text] [Related]
10. Selection of retrovirally transduced cells to enhance the efficiency of gene therapy.
Medin JA; Karlsson S
Proc Assoc Am Physicians; 1997 Mar; 109(2):111-9. PubMed ID: 9069579
[TBL] [Abstract][Full Text] [Related]
11. [Technology for gene transfer into hematopoietic stem cells (Part 2)].
Ozawa K
Hum Cell; 1999 Mar; 12(1):57-61. PubMed ID: 10457906
[TBL] [Abstract][Full Text] [Related]
12. Selective expansion of transduced cells for hematopoietic stem cell gene therapy.
Kume A; Hanazono Y; Mizukami H; Okada T; Ozawa K
Int J Hematol; 2002 Nov; 76(4):299-304. PubMed ID: 12463591
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
